Artia Global Partners as of Dec. 31, 2022
Portfolio Holdings for Artia Global Partners
Artia Global Partners holds 25 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Novo-nordisk A S Adr (NVO) | 19.1 | $50M | 371k | 135.34 | |
| Eli Lilly & Co. (LLY) | 14.5 | $38M | 104k | 365.84 | |
| Argenx Se Sponsored Adr (ARGX) | 12.3 | $32M | 85k | 378.83 | |
| Merck & Co (MRK) | 11.2 | $29M | 264k | 110.95 | |
| Karuna Therapeutics Ord | 7.4 | $20M | 99k | 196.50 | |
| Abbvie (ABBV) | 5.6 | $15M | 91k | 161.61 | |
| Moderna (MRNA) | 5.1 | $13M | 75k | 179.62 | |
| Iveric Bio | 4.1 | $11M | 505k | 21.41 | |
| Biogen Idec (BIIB) | 3.2 | $8.3M | 30k | 276.92 | |
| Seagen | 2.5 | $6.6M | 51k | 128.51 | |
| Biontech Se Sponsored Ads (BNTX) | 2.1 | $5.6M | 37k | 150.22 | |
| Neurocrine Biosciences (NBIX) | 2.0 | $5.4M | 45k | 119.44 | |
| Astrazeneca Sponsored Adr (AZN) | 2.0 | $5.3M | 78k | 67.80 | |
| Alnylam Pharmaceuticals (ALNY) | 1.4 | $3.8M | 16k | 237.65 | |
| BioMarin Pharmaceutical (BMRN) | 1.1 | $2.9M | 28k | 103.49 | |
| Thermo Fisher Scientific (TMO) | 1.1 | $2.8M | 5.1k | 550.69 | |
| Prometheus Biosciences | 0.9 | $2.5M | 22k | 110.00 | |
| Intra Cellular Therapies (ITCI) | 0.8 | $2.2M | 42k | 52.92 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $2.1M | 7.1k | 288.78 | |
| Moderna Call Call Option | 0.7 | $1.8M | 10k | 179.62 | |
| Viking Therapeutics (VKTX) | 0.5 | $1.2M | 131k | 9.40 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.4 | $1.0M | 40k | 26.13 | |
| Waters Corporation (WAT) | 0.4 | $975k | 2.8k | 342.58 | |
| Amylyx Pharmaceuticals (AMLX) | 0.3 | $883k | 24k | 36.95 | |
| Kymera Therapeutics (KYMR) | 0.3 | $749k | 30k | 24.96 |
